Janssen’s AdVac® technology

428   2 years ago
428   2 years ago
For more than 20 years, Johnson & Johnson has invested in vaccine capabilities. Our approach to the research and development of vaccines fuses a start-up mindset with deep scientific expertise to prevent some of the most life-threatening infectious diseases.
Please log in or register to post comments